Paper6138080
Pharmacokinetics and bioavailability of midazolam in man.
Heizmann P and 2 others. Br J Clin Pharmacol, 1983. Cited by 255 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Pharmacokinetics and bioavailability of midazolam in man. Papers, record 6138080. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6138080
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Anxiety Agents | Major topic |
| Benzodiazepines | Major topic |
| Administration, Oral | |
| Adult | |
| Biological Availability | |
| Humans | |
| Hydroxylation | |
| Injections, Intravenous | |
| Kinetics | |
| Midazolam |
Source PubMed
References4
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23,388 | Determination of water soluble imidazo-1,4-benzodiazepines in blood by electron- capture gas--liquid chromatography and in urine by differential pulse polaragraphy. | J Chromatogr | 1978 | https://conductscience.org/library/papers/23388 | PubMed |
| 2 | 6,114,686 | Automated gas chromatography for studies of midazolam pharmacokinetics. | Anesthesiology | 1981 | https://conductscience.org/library/papers/6114686 | PubMed |
| 3 | 6,116,606 | The pharmacokinetics of midazolam in man. | Eur J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/6116606 | PubMed |
| 4 | 7,199,324 | Excretion and metabolism of 14C-midazolam in humans following oral dosing. | Arzneimittelforschung | 1981 | https://conductscience.org/library/papers/7199324 | PubMed |
Cited by96
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 255 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,771,268 | Development of an isavuconazole physiologically-based pharmacokinetic model for adult and pediatric populations. | J Pharmacokinet Pharmacodyn | 2026 | https://conductscience.org/library/papers/42771268 | PubMed |
| 42,625,210 | Introduction to Single-Cell Physiologically-Based Pharmacokinetic (scPBPK) Models. | CPT Pharmacometrics Syst Pharmacol | 2026 | https://conductscience.org/library/papers/42625210 | PubMed |
| 42,033,156 | Midazolam Dosing During CRRT: A Combined Ex Vivo and Physiologically-Based Pharmacokinetic Approach. | CPT Pharmacometrics Syst Pharmacol | 2026 | https://conductscience.org/library/papers/42033156 | PubMed |
| 41,961,126 | A structure-preserving hybrid learning framework for compartmental pharmacokinetic models. | J Pharmacokinet Pharmacodyn | 2026 | https://conductscience.org/library/papers/41961126 | PubMed |
| 41,959,229 | Introduction to Single-cell Physiologically-Based Pharmacokinetic (scPBPK) Models. | bioRxiv | 2026 | https://conductscience.org/library/papers/41959229 | PubMed |
| 41,667,911 | Analysis of the Correlation Between Membrane Permeability in RPMI 2650 Cells and Human Nasal Absorption. | AAPS PharmSciTech | 2026 | https://conductscience.org/library/papers/41667911 | PubMed |
| 41,489,333 | Modeling Metabolite Kinetics with a Partial Differential Equation-Based Hepatic Sinusoidal Model and MALDI-Mass Spectrometry Imaging of Verapamil and Its Metabolites. | J Med Chem | 2026 | https://conductscience.org/library/papers/41489333 | PubMed |
| 41,255,293 | The Ketamine Trial for Acute Suicidality (KETA): Study Protocol of a Double-Blind Randomized Placebo-Controlled Superiority Trial on Intranasal Racemic Ketamine Compared to the Active Placebo Intranasal Midazolam as Treatment for Acute Suicidality. | Int J Methods Psychiatr Res | 2025 | https://conductscience.org/library/papers/41255293 | PubMed |
| 40,829,518 | A primary human Gut/Liver microphysiological system to estimate human oral bioavailability. | Drug Metab Dispos | 2025 | https://conductscience.org/library/papers/40829518 | PubMed |
| 40,700,225 | Sedation Methods in Paediatric Auditory Electrophysiologic Testing: A Narrative Review. | Audiol Res | 2025 | https://conductscience.org/library/papers/40700225 | PubMed |
| 38,403,792 | Distribution and elimination kinetics of midazolam and metabolites after post-resuscitation care: a prospective observational study. | Sci Rep | 2024 | https://conductscience.org/library/papers/38403792 | PubMed |
| 38,370,247 | Benefits of remimazolam as an anesthetic sedative for older patients: A review. | Heliyon | 2024 | https://conductscience.org/library/papers/38370247 | PubMed |
| 38,361,163 | Towards More Robust Evaluation of the Predictive Performance of Physiologically Based Pharmacokinetic Models: Using Confidence Intervals to Support Use of Model-Informed Dosing in Clinical Care. | Clin Pharmacokinet | 2024 | https://conductscience.org/library/papers/38361163 | PubMed |
| 37,242,680 | Application of Physiologically Based Pharmacokinetic Modeling to Predict Drug-Drug Interactions between Elexacaftor/Tezacaftor/Ivacaftor and Tacrolimus in Lung Transplant Recipients. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37242680 | PubMed |
| 36,642,822 | Clinical assessment of gepotidacin (GSK2140944) as a victim and perpetrator of drug-drug interactions via CYP3A metabolism and transporters. | Clin Transl Sci | 2023 | https://conductscience.org/library/papers/36642822 | PubMed |
| 36,195,807 | Quantification of the Time Course of CYP3A Inhibition, Activation, and Induction Using a Population Pharmacokinetic Model of Microdosed Midazolam Continuous Infusion. | Clin Pharmacokinet | 2022 | https://conductscience.org/library/papers/36195807 | PubMed |
| 35,994,774 | A Participant-Level Integrative Data Analysis of Differential Placebo Response for Suicidal Ideation and Nonsuicidal Depressive Symptoms in Clinical Trials of Intravenous Racemic Ketamine. | Int J Neuropsychopharmacol | 2022 | https://conductscience.org/library/papers/35994774 | PubMed |
| 35,776,074 | Impact of Inflammation on Midazolam Metabolism in Severe COVID-19 Patients. | Clin Pharmacol Ther | 2022 | https://conductscience.org/library/papers/35776074 | PubMed |
| 35,648,149 | Correlations between 4β-hydroxycholesterol and hepatic and intestinal CYP3A4: protein expression, microsomal ex vivo activity, and in vivo activity in patients with a wide body weight range. | Eur J Clin Pharmacol | 2022 | https://conductscience.org/library/papers/35648149 | PubMed |
| 35,388,227 | The pharmacokinetics and pharmacodynamics of midazolam after intravenous administration to donkeys (Equus africanus asinus). | Can J Vet Res | 2022 | https://conductscience.org/library/papers/35388227 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6138080
GET https://conductscience.org/api/papers/v1/6138080/cited_by?page=2